Targeted interventions could substantially reduce the burden of stroke.

A history of diabetes or high cholesterol (especially LDL) can speed cognitive decline in patients with Alzheimer's disease.

A tailored-treatment strategy prevents more CAD events than a treat-to-target approach.

Overall prevalence for high LDL levels fell from 31.5% in 1999-2000 to 21.2% in 2005-2006.

Serum triglyceride levels may allow clinicians to predict which patients with type 2 diabetes will develop neuropathy, while fenofibrate therapy can reduce the risk of diabetes-related amputations by more than a third.

A 79-year-old Caucasian man with a history of chest pain, light-headedness, and diaphoresis was admitted to rule out acute coronary syndrome. He incidentally noted a bruise that had appeared spontaneously on his chest without trauma four days prior to admission.

Diagnosing atrial fibrillation could sharply reduce strokes in the United States, and primary-care physicians have a key role to play, according to experts at the American College of Cardiology.

A 63-year-old woman wants to discontinue the simvastatin (Zocor) 10 mg she is taking for hypercholesterolemia because she believes the medication is causing her to lose her hair. Is there any evidence supporting this side effect of Zocor?

Three recent studies indicate that the venerable Framingham risk score goes only so far as a predictor of cardiovascular problems.

Even as researchers are fine-tuning approaches to preventing primary coronary events, a new analysis of unrelated CDC data found that primary-care providers need to focus more on secondary stroke prevention too.